First test of new cancer drug in humans begins
Disease control
Terminated
This was an early-stage trial to test the safety and find the right dose of a new drug called ESG206 for adults with advanced B-cell blood cancers like lymphoma. The study was for people whose cancer had worsened despite standard treatments and who had no other good options. Rese…
Phase: PHASE1 • Sponsor: Shanghai Escugen Biotechnology Co., Ltd • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC